A Non-Invasive Integrated Model for Accurate Preoperative Identification of the Aggressive Macrotrabecular-Massive Subtype of Hepatocellular Carcinoma: A Single-Center Retrospective Study
Open Access
- 16 March 2026
- journal article
- research article
- Published by MDPI AG in Diagnostics
- Vol. 16 (6) , 877
Abstract
Objective: The objective of this study was to develop and validate a predictive model for MTM-HCC by integrating preoperative ultrasound (US) and contrast-enhanced ultrasound (CEUS) features with relevant clinical characteristics. Methods: This retrospective study analyzed data from patients with histopathologically confirmed hepatocellular carcinoma who underwent preoperative CEUS examination at the Ultrasound Department of the Lanzhou University Second Hospital between December 2021 and March 2025. The study cohort comprised 45 patients diagnosed with MTM-HCC and 194 patients with non-MTM-HCC. Ultrasound and CEUS images were independently reviewed by two senior abdominal radiologists with extensive experience in hepatic imaging, ensuring objective feature assessment. Clinical variables and imaging characteristics were systematically compared between the two groups to identify distinguishing patterns. To evaluate the associations among clinical data, ultrasound-derived features, and MTM-HCC, univariate analyses were first performed, followed by multivariate logistic regression to construct and assess predictive models. Results: A total of 239 patients (mean age: 57.28 ± 9.60 years; 187 males and 52 females) were included in the analysis. Among them, 45 HCC patients (18.8%) were classified as MTM-HCC. Multivariate analysis identified four independent predictors: elevated alpha-fetoprotein (AFP ≥ 467 ng/mL) (OR = 8.5, 95% CI: 4.2–17.30; p < 0.001), presence of non-enhancing necrotic areas (OR = 5.92, 95% CI: 1.82–19.30, p = 0.003), intratumoral arteries (OR = 6.61, 95% CI: 2.28–19.22, p < 0.001), and peritumoral feeding arteries (OR = 3.13, 95% CI: 1.15–8.50, p = 0.025). Conclusions: An integrated prediction model that combines ultrasound imaging and clinical parameters offers a feasible, non-invasive approach for accurate preoperative identification of MTM-HCC.Keywords
Funding Information
- National Natural Science Foundation of China (82371969)
- National Natural Science Foundation of China (82460349)
- the Key Science and Technology Project of Gansu Province-Social Development Category (232DFA006)
This publication has 52 references indexed in Scilit:
- Diagnostic accuracy of preoperative MRI in assessing macrotrabecular-massive subtype of hepatocellular carcinoma: a systematic review and meta-analysisEuropean Radiology, 2025
- Deep learning model based on contrast-enhanced ultrasound for predicting vessels encapsulating tumor clusters in hepatocellular carcinomaEuropean Radiology, 2024
- MRI imaging features for predicting macrotrabecular-massive subtype hepatocellular carcinoma: a systematic review and meta-analysisEuropean Radiology, 2024
- Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma based on B-Mode US and CEUSEuropean Radiology, 2022
- Comprehensive clinicopathologic study of alpha fetoprotein‐expression in a large cohort of patients with hepatocellular carcinomaInternational Journal of Cancer, 2021
- Macrotrabecular-massive hepatocellular carcinoma: imaging identification and prediction based on gadoxetic acid–enhanced magnetic resonance imagingEuropean Radiology, 2021
- Vessels Encapsulating Tumor Clusters (VETC) Is a Powerful Predictor of Aggressive Hepatocellular CarcinomaHepatology, 2019
- Macrotrabecular‐massive hepatocellular carcinomaHepatology, 2018
- LI-RADS: a glimpse into the futureAbdominal Radiology, 2018
- Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interactionHepatology, 2017